2019
DOI: 10.1007/s40266-018-00633-w
|View full text |Cite
|
Sign up to set email alerts
|

Pigmentation Disorders in the Elderly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 80 publications
0
12
0
Order By: Relevance
“…Validating the model’s potential to identify targetable drivers of age-related tissue pathology, hi T-bearing nude mice showed enhanced age-related pathology in skin and brain, specifically depigmentation and neuroinflammation ( Jurgens and Johnson, 2012 ; Lourbopoulos et al, 2015 ; Armenta et al, 2019 ; Rheins et al, 1986 ). Enhanced neuroinflammation in particular was found to require sustained presence of CD8 T cells in brain, as well as their fully intact pro-inflammatory function, as genetic knockout of the Perforin-1 gene in donor T cells eliminated their sustained presence in brain, while knockout of the IFNγ gene in donor T cells did not.…”
Section: Discussionmentioning
confidence: 99%
“…Validating the model’s potential to identify targetable drivers of age-related tissue pathology, hi T-bearing nude mice showed enhanced age-related pathology in skin and brain, specifically depigmentation and neuroinflammation ( Jurgens and Johnson, 2012 ; Lourbopoulos et al, 2015 ; Armenta et al, 2019 ; Rheins et al, 1986 ). Enhanced neuroinflammation in particular was found to require sustained presence of CD8 T cells in brain, as well as their fully intact pro-inflammatory function, as genetic knockout of the Perforin-1 gene in donor T cells eliminated their sustained presence in brain, while knockout of the IFNγ gene in donor T cells did not.…”
Section: Discussionmentioning
confidence: 99%
“…The involvement of PHBs in melanin production suggests that targeting PHBs may be a promising therapeutic approach for pigmentary disorders, which can be common in the elderly population ( Armenta et al, 2019 ). Melanogenin and melanogenin analogs also have potential as treatments against cancer since they can trigger apoptosis in tumor cells, such as melanoma cells ( Djehal et al, 2018 ).…”
Section: Prohibitin As a Therapeutic Targetmentioning
confidence: 99%
“…Melanocyte density is usually found to reduce 10-20% per decade in humans aged 30 years and older [46]. Despite this, hyperpigmentation is a Skin Pharmacol Physiol 2021;34:351-362 DOI: 10.1159/000514995 common phenomenon in the aging populations as a result of focal melanocyte proliferation and aggregation [47,48].…”
Section: Influence Of Demographic Background On Biophysical Parametersmentioning
confidence: 99%